KMT2A and acute myeloid leukemia: Notably, the expression level of ALOX5 in MLL-rearranged AML is also significantly lower than that in other AML subtypes (Fig. 1a); such pattern was also observed in an independent large-scale AML dataset (i.e., GSE1446830, 31) (Fig. 1b).